Medical Policy

Eculizumab (Soliris) and Ravulizumab (Ultomiris)

View Document ›

Edaravone (Radicava)

View Document ›

EGFR Testing for Non-Small Cell Lung Cancer TKI Response

View Document ›

Electric Breast Pumps

View Document ›

Electrical Nerve Stimulation

View Document ›

Electrical Stimulation Devices for the Treatment of Arthritis

View Document ›

Electrical Stimulation of the Spine as an Adjunct to Spinal Fusion Procedures

View Document ›

Electroencephalogram (EEG) Technologies

View Document ›

Electronystagmography (ENG) and Videonystagmography (VNG) Services

View Document ›

Electroretinography

View Document ›

Elosulfase alfa (Vimizim)

View Document ›

Elotuzumab (Empliciti)

View Document ›

Emapalumab-lzsg (Gamifant)

View Document ›

Esketamine (Spravato)

View Document ›

Esophageal pH Monitoring

View Document ›

Eustachian Tube Balloon Dilation

View Document ›

Excision Repair Cross-Complementing Factor 1 (ERCC1) Analysis for Non-Small Cell Lung Cancer

View Document ›

Exondys 51 (eteplirsen)

View Document ›

Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies

View Document ›

Experimental-Investigational Services

View Document ›

External Counterpulsation (ECP)

View Document ›

External Hearing Aids, Auditory Brainstem Implant, Bone-Anchored Hearing Devices and Audiological Testing

View Document ›

Extracorporeal Photopheresis

View Document ›

Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions

View Document ›